Land: Nýja-Sjáland
Tungumál: enska
Heimild: Medsafe (Medicines Safety Authority)
Aprotinin 10000 kIU/mL equivalent to to 200 mg/ml.
Link Pharmaceuticals Ltd
Aprotinin 10000 kIU/mL (Equiv. to 200 mg/ml.)
100000kIU/10mL
Solution for injection
Active: Aprotinin 10000 kIU/mL equivalent to to 200 mg/ml. Excipient: Hydrochloric acid Sodium chloride Sodium hydroxide Water for injection
Vial, glass, 1x50ml, 50 mL
Prescription
Prescription
Bayer AG
Package - Contents - Shelf Life: Vial, glass, - 50 mL - 36 months from date of manufacture stored at or below 25°C - Vial, glass, - 100 mL - 36 months from date of manufacture stored at or below 25°C - Vial, glass, - 200 mL - 36 months from date of manufacture stored at or below 25°C
1969-12-31
TRASYLOL ® Aprotinin CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about TRASYLOL. It does not contain all available information. It does NOT take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you receiving TRASYLOL against the benefits they expect it will have for you. Please read this leaflet carefully. If you have any concerns about being given this medicine, ask your doctor or your pharmacist. CONTENTS OF THIS LEAFLET • WHAT TRASYLOL IS USED FOR • BEFORE YOU ARE GIVEN TRASYLOL • HOW TRASYLOL IS GIVEN • WHILE YOU ARE RECEIVING TRASYLOL • SIDE EFFECTS • AFTER YOU HAVE RECEIVED TRASYLOL • PRODUCT DESCRIPTION WHAT TRASYLOL IS USED FOR TRASYLOL is used to prevent and treat abnormal bleeding conditions during Coronary Artery Bypass Graft (CABG) surgery. TRASYLOL is a sterile intravenous medication. It contains the drug APROTININ which is a protein obtained and purified from cow’s lungs. Aprotinin is similar to a protein that naturally occurs in humans. Being given TRASYLOL helps to supplement natural processes controlling bleeding while you are undergoing surgery. TRASYLOL is only used in hospitals. Your doctor may have prescribed TRASYLOL for another reason. Ask your doctor if you have any questions about why TRASYLOL is being prescribed. BEFORE YOU ARE GIVEN TRASYLOL WHEN YOU MUST NOT HAVE TRASYLOL You must not have TRASYLOL if: • you are allergic to aprotinin • you have been treated with aprotinin in the last 12 months • you are sitting or standing up. You must be lying down when you are given the drug You must not be given TRASYLOL that has passed the expiry date. This date appears after the words “EXP” or “EXPIRY” printed o Lestu allt skjalið
DATASHEET 1 TRASYLOL ® _APROTININ _ GENERAL INFORMATION _QUALITATIVE AND QUANTITATIVE COMPOSITION _ 1 vial of 50 mL/100 mL/200 mL contains aprotinin concentrated solution, corresponding to 500,000 KIU (Kallikrein Inhibitor Units) /1,000,000 KIU/2,000,000 KIU in sterile isotonic sodium chloride solution. 500,000 KIU (approx. 70 mg aprotinin) corresponds to 277.8 Eur.Ph.Units 1,000,000 KIU (approx. 140 mg aprotinin) corresponds to 555.6 Eur.Ph.Units 2,000,000 KIU (approx. 280 mg aprotinin) corresponds to 1111.1 Eur.Ph.Units _PHARMACEUTICAL FORM _ TRASYLOL is a colourless clear solution for infusion. _DESCRIPTION _ _ _ Aprotinin is a highly purified natural proteinase inhibitor obtained from bovine lungs. It is made up of 58 amino acid residues that are arranged in a single polypeptide chain, cross-linked by three disulfide bridges. It has a molecular weight of 6512 Daltons and a chemical formula of C 284 H 432 N 84 O 79 S 7 . It is supplied as a clear, colourless, sterile isotonic solution for intravenous administration. Each millilitre contains 10,000 KIU (1.4 mg/mL) and 9 mg sodium chloride in water for injection. Hydrochloric acid and/or sodium hydroxide is used to adjust the pH to 4.5-6.5. CLINICAL PARTICULARS _INDICATIONS _ TRASYLOL is used prophylactically to reduce perioperative blood loss and to reduce the need for blood transfusion in adult patients undergoing cardiopulmonary bypass in the course of isolated coronary artery bypass graft surgery, where the risk of bleeding is high (impaired haemostasis, e.g. presence of aspirin), or where transfusion is unavailable or unacceptable. _POSOLOGY AND METHOD OF ADMINISTRATION _ RECOMMENDED USUAL DOSE: The following dosage regimen is recommended for adult patients: Owing to the risk of allergic/anaphylactic reactions, a 1 mL (10,000 KIU) test dose should be Lestu allt skjalið